Skip to main content
Signal8

Petree Daniel H

SEC insider (Form 3/4/5 filer). CIK 0001294939. Director at SUTRO BIOPHARMA, INC. (STRO). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Petree Daniel H has filed insider reports for

  • SUTRO BIOPHARMA, INC. (STRO): Director
Petree Daniel H profile photo

Petree Daniel H

CIK: 0001294939

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SUTRO BIOPHARMA, INC. logo
STRO

SUTRO BIOPHARMA, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    10K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Dec 23, 2025
    Award

    Stock Option (right to buy)

    Direct
    1.5K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 6, 2025
    Award

    Stock Option (right to buy)

    Direct
    50K shares-

1-3 of 3